Top Companies in Biobanking

The biobanking market is projected to reach USD 7.65 billion in 2025 and USD 11.82 billion by 2030, at a CAGR of 9.1% during the forecast period. The key factors driving the growth of this market are the growing focus on precision or personalized medicine leading to the requirement of preserving patient samples, continuously expanding cell & gene therapy pipeline which uses autologous or allogeneic source of cell lines that are maintained by biobanks, and end-to-end automation for sample handling & storage which is enhancing the capabilities of biobank market players. Additionally, the focus on sustainability and green-lab solutions offers growth opportunities for market players. However, long-term funding stability for public biobanks is a challenge faced by the market.

The global biobanking products market is competitive with leading players contributing to the significant share, including Thermo Fisher Scientific Inc. (US), PHC Holdings Corporation (Japan), Becton, Dickinson and Company (BD) (US), Qiagen (Germany), and Merck KGaA (Germany). The market players have adopted new product launches, acquisitions, agreements, collaborations, and geographical expansions to strengthen their position in the global biobanking market. The biobanking services market is also competitive, with key players, including Labcorp (US), Eurofins Scientific (Luxembourg), Azenta (US), and Cryoport (US), among other players.

To know about the assumptions considered for the study download the pdf brochure

In April 2024, Thermo Fisher Scientific Inc. launched a ULT freezer named TSX Universal Series ULT Freezers. In March 2025, Cryoport announced the launch of MVE Biological Solutions' High-Efficiency 800 C, the latest addition to its next-generation High-Efficiency (HE) Series of cryogenic freezers. The HE 800 C combines ergonomic features and consistent performance in a compact size to meet the evolving needs of fertility clinics, biorepositories, and clinical laboratories.

Thermo Fisher Scientific Inc. (US)

Thermo Fisher Scientific Inc. is a global leader in laboratory products and services, with a strong strategic position in the biobanking market, driven by its broad portfolio of advanced solutions for sample preservation, storage, and analysis. Its extensive product offering includes high-performance freezers, automated sample management systems, and consumables designed for biobanks. Thermo Fisher has strategically invested in expanding its biobanking solutions to support emerging areas such as precision medicine, genomics, and cell therapy. Its innovation strategy is underscored by its acquisition of companies like Life Technologies, which strengthened its capabilities in genomics and biopreservation, making it a key player in high-throughput biobanking technologies. Additionally, its global presence, robust distribution network, and strong partnerships with biopharma and academic institutions place it in a prime position to meet the growing demands of biobanks worldwide.

Becton, Dickinson and Company (Germany)

BD has established a strong strategic position in the biobanking products market through its innovative solutions designed for sample collection, storage, and management. Its portfolio includes a wide range of specialized consumables, such as blood collection tubes, cryovials, and storage solutions, as well as advanced diagnostic systems that integrate with biobanks to enhance data tracking and sample integrity. The company’s leadership in biobanking is further strengthened by its focus on developing cutting-edge technologies for blood-based diagnostics and sample handling, which is crucial for high-quality sample preservation. It has also invested in expanding its manufacturing and R&D capabilities, particularly in the US and Asia, positioning itself as a key player to support the growing needs of biobanks globally. Its strategic focus on automation and digitization has enabled it to offer integrated, scalable solutions that help biobanks streamline operations, reduce costs, and improve efficiency.

PHC Holdings (Germany)

PHC Holdings, through its subsidiary PHCbi, holds a strong strategic position in the biobanking products market by offering high-performance, energy-efficient freezers, refrigerators, and incubators tailored for biological sample preservation. With a long history of providing reliable and innovative solutions for life sciences and healthcare applications, PHC Holdings has gained significant traction in the biobanking sector, especially in the Asia Pacific region. Its focus on sustainable, eco-friendly products, including low-energy storage systems, aligns with the growing demand for greener technologies in the biobanking industry. Its expertise in cold storage technologies, combined with its ability to cater to the specific needs of biobanks, such as cryogenic storage and temperature monitoring, has strengthened its position as a trusted provider for biobanks worldwide. Furthermore, its ongoing investments in R&D and strategic expansions, such as the growing footprint in emerging markets, ensure continued relevance in the fast-evolving biobanking landscape.

Market Ranking

The biobanking products and services market is competitive. The top five players for each of the markets hold >45% and 30% shares respectively.

In the biobanking products market, Thermo Fisher maintains a strong position through a comprehensive portfolio of equipment and consumables supported by ongoing investments in automation and scalability. BD (Becton, Dickinson and Company) has carved out a significant presence in the biobanking market with its diverse portfolio of products designed for sample collection, storage, and preservation. BD’s PreAnalytiX and BD Vacutainer product lines are widely used in biobanks for blood collection and sample processing, providing reliable, high-quality tools for the biobanking industry. PHC Holdings (through its PHCbi division) holds a strong position in the biobanking equipment market, driven by its innovative solutions for biological sample storage, particularly its biological freezers and cryogenic storage systems.

In the biobanking services market, Labcorp is a leading provider of comprehensive biobanking services, with a strong market position driven by its wide range of clinical and research solutions. Eurofins Scientific is a recognized global leader in the biobanking services market, providing extensive biological sample storage and analysis solutions to the pharmaceutical, biotechnology, and healthcare industries. Cryoport holds a significant market share in the biobanking services sector, specializing in the cryogenic storage and transportation of biological samples. Azenta is a key player in the biobanking services market, offering comprehensive sample storage and management solutions across the life sciences and healthcare sectors.

Related Reports:

Biobanking Market by Product (Equipment, Consumables, Software), Services (Virtual), Operation (Automated), Workflow (Storage, Collection, Transport), Sample (Blood, Cell Lines, Nucleic Acids), Application, Ownership, End User - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com